1. Avinash Tejasvi, M L, Maragathavalli, G, Putcha, Uday Kumar, Vijayaraghavan, R, Anulekha Avinash, C K. . Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients. In Indian journal of pathology & microbiology, 63, 538-543. doi:10.4103/IJPM.IJPM_964_19. https://pubmed.ncbi.nlm.nih.gov/33154302/
2. Koutsoukos, Konstantinos, Andrikopoulou, Angeliki, Dedes, Nikos, Bamias, Aristotelis, Dimopoulos, Meletios-Athanasios. 2020. Clinical Perspectives of ERCC1 in Bladder Cancer. In International journal of molecular sciences, 21, . doi:10.3390/ijms21228829. https://pubmed.ncbi.nlm.nih.gov/33266377/
3. Nicoś, Marcin, Rolska-Kopińska, Anna, Krawczyk, Paweł, Szczyrek, Michał, Milanowski, Janusz. 2020. Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients. In Archives of medical science : AMS, 17, 474-480. doi:10.5114/aoms.2020.92572. https://pubmed.ncbi.nlm.nih.gov/33747282/
4. Huang, Yu-Liang, Wu, Jun-Rong, Fang, Min, Huang, Ling-Sha, Zhu, Bo. . The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. In Medicine, 98, e15090. doi:10.1097/MD.0000000000015090. https://pubmed.ncbi.nlm.nih.gov/30946366/
5. Gómez-Díaz, Benjamín, DE LA Luz Ayala-Madrigal, María, Gutiérrez-Angulo, Melva, Canto, Patricia, López-Hernández, Luz Berenice. 2015. Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer. In Oncology letters, 9, 1657-1661. doi:. https://pubmed.ncbi.nlm.nih.gov/25789018/
6. Zhang, Q, Lv, L Y, Li, B J, Zhang, J, Wei, F. 2015. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma. In Genetics and molecular research : GMR, 14, 11235-41. doi:10.4238/2015.September.22.17. https://pubmed.ncbi.nlm.nih.gov/26400354/
7. Ceppi, P, Volante, M, Novello, S, Papotti, M, Scagliotti, G V. 2006. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. In Annals of oncology : official journal of the European Society for Medical Oncology, 17, 1818-25. doi:. https://pubmed.ncbi.nlm.nih.gov/16980606/
智鼠故事 
